ANITA ELLIOTT: Open Payments
NPI 1932510757 · AMERICUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 63 payments from 12 companies in 2025. Trend: 2023 $753 · 2024 $1,280 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $413 |
| Janssen Biotech, Inc. | 7 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Ardelyx, Inc. | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 7 | $43 |
| Lilly USA, LLC | 2 | $43 |
| Madrigal Pharmaceuticals | 1 | $24 |
| GENZYME CORPORATION | 1 | $22 |
Products named: RINVOQ, TREMFYA, ENTYVIO, CREON, IBSRELA, LINZESS, XIFAXAN, MAVYRET.
Industry payments across GA — which companies pay providers there.
